fluorobenzenes has been researched along with Liver Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dautović, E; Halilčević, D; Hatkić, A; Husejnović, MŠ; Rustemović-Čorbić, M; Smajlović, A; Softić, A; Srabović, N | 1 |
| Aggarwal, M; Battalora, M; Bomann, WH; LeBaron, MJ; Peffer, RC; Rowe, RR; Tinwell, H; Werner, C | 1 |
| Guo, C; He, L; Liu, HH; Liu, XD; Pan, GY; Ren, J; Sheng, JJ; Yang, Y; Yao, D; Zhou, WP | 1 |
| Deguchi, Y; Hirose, Y; Isobe, N; Kawamura, S; Lake, BG; Nagahori, H; Nishioka, K; Okuno, Y; Tomigahara, Y; Uwagawa, S; Yamada, T | 1 |
| Dandri, M; Kah, J; Keller, AD; Montalbano, R; Ocker, M; Sass, G; Sirma, H; Tiegs, G; Volz, T; Wüstenberg, A | 1 |
5 other study(ies) available for fluorobenzenes and Liver Neoplasms
| Article | Year |
|---|---|
Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin.
Topics: Atorvastatin; Carcinoma, Hepatocellular; Fluorobenzenes; Glucose; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; Pyrimidines; Pyrroles; Reactive Oxygen Species; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2023 |
Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors.
Topics: Animals; Biomarkers, Tumor; Constitutive Androstane Receptor; Cyclopropanes; Datasets as Topic; Fluorobenzenes; Liver Neoplasms; Mice; Picolines; Rats; Receptors, Cytoplasmic and Nuclear | 2018 |
Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus.
Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Glucose; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Oleic Acid; Pyrimidines; Rats; Rats, Wistar; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides | 2014 |
Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes.
Topics: Adult; Animals; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Cyclopropanes; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2B6; DNA Replication; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fluorobenzenes; Hepatocytes; Humans; Liver Neoplasms; Male; Middle Aged; Oxidoreductases, N-Demethylating; Phenobarbital; Rats; Rats, Wistar; Species Specificity | 2009 |
Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Screening Assays, Antitumor; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Gene Expression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipid Metabolism; Liver Neoplasms; Lovastatin; Mice; Mice, Inbred C57BL; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tumor Suppressor Protein p53 | 2012 |